Given that DCAF7 is associated with cisplatin resistance, as shown by the GSEA results in Figure 1D, we then generated DCAF7‐overexpressing and DCAF7‐knockdown NPC cells (Figure 1E; Figure S2A, Supporting Information) and treated these cells with cisplatin. This evidence concerns the gene DCAF7 and nasopharyngeal carcinoma.